TY - JOUR
T1 - Connexins in the skeleton
AU - Stains, Joseph P.
AU - Civitelli, Roberto
N1 - Funding Information:
Roberto Civitelli receives grant support from Amgen, and owns stock of Eli-Lilly, Merck, and Amgen. Joseph Stains has no conflicts of interest. Part of the work reported here was supported by NIH grants AR041255 (to RC), AR052719, AR063631 (to JPS), by the Washington University Core Center for Musculoskeletal Biology and Medicine (P30 AR057235), and by grants from the Barnes-Jewish Foundation.
Funding Information:
Roberto Civitelli receives grant support from Amgen, and ownsstock of Eli-Lilly, Merck, and Amgen. Joseph Stains has no conflictsof interest. Part of the work reported here was supported by NIHgrants AR041255 (to RC), AR052719, AR063631 (to JPS), by theWashington University Core Center for Musculoskeletal Biologyand Medicine (P30 AR057235), and by grants from the Barnes-Jewish Foundation.
Publisher Copyright:
© 2015 Elsevier Ltd.
PY - 2016/2/1
Y1 - 2016/2/1
N2 - Shaping of the skeleton (modeling) and its maintenance throughout life (remodeling) require coordinated activity among bone forming (osteoblasts) and resorbing cells (osteoclasts) and osteocytes (bone embedded cells). The gap junction protein connexin43 (Cx43) has emerged as a key modulator of skeletal growth and homeostasis. The skeletal developmental abnormalities present in oculodentodigital and craniometaphyseal dysplasias, both linked to Cx43 gene (GJA1) mutations, demonstrate that the skeleton is a major site of Cx43 action. Via direct action on osteolineage cells, including altering production of pro-osteoclastogenic factors, Cx43 contributes to peak bone mass acquisition, cortical modeling of long bones, and maintenance of bone quality. Cx43 also contributes in diverse ways to bone responsiveness to hormonal and mechanical signals. Skeletal biology research has revealed the complexity of Cx43 function; in addition to forming gap junctions and "hemichannels", Cx43 provides a scaffold for signaling molecules. Hence, Cx43 actively participates in generation and modulation of cellular signals driving skeletal development and homeostasis. Pharmacological interference with Cx43 may in the future help remedy deterioration of bone quality occurring with aging, disuse and hormonal imbalances.
AB - Shaping of the skeleton (modeling) and its maintenance throughout life (remodeling) require coordinated activity among bone forming (osteoblasts) and resorbing cells (osteoclasts) and osteocytes (bone embedded cells). The gap junction protein connexin43 (Cx43) has emerged as a key modulator of skeletal growth and homeostasis. The skeletal developmental abnormalities present in oculodentodigital and craniometaphyseal dysplasias, both linked to Cx43 gene (GJA1) mutations, demonstrate that the skeleton is a major site of Cx43 action. Via direct action on osteolineage cells, including altering production of pro-osteoclastogenic factors, Cx43 contributes to peak bone mass acquisition, cortical modeling of long bones, and maintenance of bone quality. Cx43 also contributes in diverse ways to bone responsiveness to hormonal and mechanical signals. Skeletal biology research has revealed the complexity of Cx43 function; in addition to forming gap junctions and "hemichannels", Cx43 provides a scaffold for signaling molecules. Hence, Cx43 actively participates in generation and modulation of cellular signals driving skeletal development and homeostasis. Pharmacological interference with Cx43 may in the future help remedy deterioration of bone quality occurring with aging, disuse and hormonal imbalances.
KW - Bone
KW - Cx37
KW - Cx43
KW - Gap junction
KW - Signal transduction
UR - http://www.scopus.com/inward/record.url?scp=84959202736&partnerID=8YFLogxK
U2 - 10.1016/j.semcdb.2015.12.017
DO - 10.1016/j.semcdb.2015.12.017
M3 - Review article
C2 - 26740471
AN - SCOPUS:84959202736
SN - 1084-9521
VL - 50
SP - 31
EP - 39
JO - Seminars in Cell and Developmental Biology
JF - Seminars in Cell and Developmental Biology
ER -